Scientific Literature Search

Source record

Yeast unfolds the road map toward alpha-synuclein-induced cell death.

Franssens V, Boelen E, Anandhakumar J, Vanhelmont T, Büttner S, Winderickx J.

Cell Death Differ · 2009-12-18

DOI: 10.1038/cdd.2009.203PMID: 20019751

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe.

Mukaetova-Ladinska EB, Xuereb JH, Garcia-Sierra F, Hurt J, Gertz HJ, Hills R, Brayne C, Huppert FA, Paykel ES, McGee MA, Jakes R, Honer WG, Harrington CR, Wischik CM.

ScientificWorldJournal · 2009-12-16

DOI: 10.1100/tsw.2009.151PMID: 20024519

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart.

Zhou B, von Gise A, Ma Q, Hu YW, Pu WT.

Dev Biol · 2009-12-16

DOI: 10.1016/j.ydbio.2009.12.007PMID: 20025864

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

LRRK2 variant associated with Alzheimer's disease.

Zhao Y, Ho P, Yih Y, Chen C, Lee WL, Tan EK.

Neurobiol Aging · 2009-12-16

DOI: 10.1016/j.neurobiolaging.2009.11.019PMID: 20018409

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China.

Mao XY, Burgunder JM, Zhang ZJ, An XK, Zhang JH, Yang Y, Li T, Wang YC, Chang XL, Peng R.

Neurosci Lett · 2009-12-11

DOI: 10.1016/j.neulet.2009.12.007PMID: 20004703

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Domain a' of protein disulfide isomerase plays key role in inhibiting alpha-synuclein fibril formation.

Cheng H, Wang L, Wang CC.

Cell Stress Chaperones · 2009-12-04

DOI: 10.1007/s12192-009-0157-2PMID: 19960284

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

PDbase: a database of Parkinson's disease-related genes and genetic variation using substantia nigra ESTs.

Yang JO, Kim WY, Jeong SY, Oh JH, Jho S, Bhak J, Kim NS.

BMC Genomics · 2009-12-03

DOI: 10.1186/1471-2164-10-s3-s32PMID: 19958497

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.

Arbouw ME, Movig KL, Egberts TC, Poels PJ, van Vugt JP, Wessels JA, van der Straaten RJ, Neef C, Guchelaar HJ.

Eur J Clin Pharmacol · 2009-12-01

DOI: 10.1007/s00228-009-0708-6PMID: 19669131

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

(1)H, (13)C and (15)N assignments of a camelid nanobody directed against human alpha-synuclein.

Vuchelen A, O'Day E, De Genst E, Pardon E, Wyns L, Dumoulin M, Dobson CM, Christodoulou J, Hsu ST.

Biomol NMR Assign · 2009-12-01

DOI: 10.1007/s12104-009-9182-4PMID: 19763886

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Structural properties of pore-forming oligomers of alpha-synuclein.

Kim HY, Cho MK, Kumar A, Maier E, Siebenhaar C, Becker S, Fernandez CO, Lashuel HA, Benz R, Lange A, Zweckstetter M.

J Am Chem Soc · 2009-12-01

DOI: 10.1021/ja9077599PMID: 19888725

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.

Rajput A, Vilariño-Güell C, Rajput ML, Ross OA, Soto-Ortolaza AI, Lincoln SJ, Cobb SA, Heckman MG, Farrer MJ, Rajput A.

Mov Disord · 2009-12-01

DOI: 10.1002/mds.22795PMID: 19890971

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.

Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, Mickel SF, Andrews HF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Caccappolo E, Ottman R, Clark LN, Marder KS.

Arch Neurol · 2009-12-01

DOI: 10.1001/archneurol.2009.267PMID: 20008657

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

15.097 articles found

Yeast unfolds the road map toward alpha-synuclein-induced cell death.

Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe.

Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart.

LRRK2 variant associated with Alzheimer's disease.

Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China.

Domain a' of protein disulfide isomerase plays key role in inhibiting alpha-synuclein fibril formation.

PDbase: a database of Parkinson's disease-related genes and genetic variation using substantia nigra ESTs.

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.

(1)H, (13)C and (15)N assignments of a camelid nanobody directed against human alpha-synuclein.

Structural properties of pore-forming oligomers of alpha-synuclein.

Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.

Filters